Immunohistochemistry of the S phase related proliferating cell nuclear antigen (PCNA) was studied as an alternative to ex-vivo bromodeoxyuridine (BrdU) immunohistochemistry for assessment of human colonic cell proliferation. From 16 subjects without colonic disease biopsy specimens were collected from five different sites along the colorectum and processed for BrdU 
Abstract
Immunohistochemistry of the S phase related proliferating cell nuclear antigen (PCNA) was studied as an alternative to ex-vivo bromodeoxyuridine (BrdU) immunohistochemistry for assessment of human colonic cell proliferation. From 16 subjects without colonic disease biopsy specimens were collected from five different sites along the colorectum and processed for BrdU and PCNA immunohistochemistry. The mean proliferation index of PCNA was significantly higher at 133% of the value obtained with BrdU. There was, however, a good correlation between the results from both techniques (r=0-6275; p<005). Decrease in proliferation index along the colorectum was seen with both staining methods but was clearer with PCNA immunohistochemistry (caecum/ascending colon v rectum: 12-0 v 7-2; p<0004). The total number of crypt cells also decreased from proximal to distal (134 to 128; p<006) but at no site correlated significantly with the proliferation index. It is concluded that in clinical cell kinetic studies staining for PCNA may serve as an attractive alternative to the BrdU incorporation assay. (Gut 1994; 35: 530-535) In experimental carcinogenesis, changes in the proliferative characteristics of the colonic mucosa have been found to come before the development of frank neoplasia.'1-In subjects at risk for the development of colorectal carcinoma similar changes have been found including increased proliferation and an abnormal distribution of proliferating cells along the colonic crypts. Therefore, stud-y of the proliferative phenotype may become an important clinical marker to identify subjects at risk to develop neoplasia and to determine early effects of treat No of crypts counted (Table I ). In some mucosal sections good BrdU staining was seen in some parts whereas in other parts crypts were clearly negative. This shows that labelling inefficiency rather than immunohistochemistry problems contributed to the comparatively low success rate. This is substantiated by the high success rate ofPCNA staining, This difference seems to be systematic as the correlation matrix is showing significant correlation (r=0 63; p<O005) (Fig 2) . Furthermore, the distribution of BrdU and PCNA immunoreactive cells along the colonic crypt was similar. In Figure 3 , this distribution over the lower, middle, and upper compartments of the colonic crypt is depicted, showing in both cases that 80% of these cells are located on the lower third and virtually none in the upper third. This is illustrated (Fig 4) in two serial sections of the same colonic crypt.
BrdU and PCNA immunoreactivity were determined in relation to the site along the human colorectum (Fig 5) . Both proliferation indices decreased from proximal to distal; this was most pronounced for the PCNA staining index with a decrease of 40% between the right sided colon and the rectum. For the PCNA staining index, the differences between rectum and sigmoid were not significant; differences with and between the descending, transverse, and ascending colon were, however, statistically significant (p=0 0004 and p=0 02 respectively).
Crypt height defined as the number ofmucosal cells present in one column of a longitudinally cut crypt, was also determined along the entire colorectum (see Fig 5) . Crypt height was the lowest in the rectum, but the differences were not statistically significant compared with descending, transverse, and ascending colon (p=0 06). BrdU immunoreactivity (correlation coefficient 0-0008, p value not significant) and PCNA immunoreactivity (correlation coefficient 0-1616, p value not significant) were not significantly correlated with the crypt height. Changes in proliferative characteristics of ranging from 49-11-3% for tritiated thymidine labelling and from 5.9-69 for BrdU. The proliferation index with BrdU was slightly higher than reported in published works (showing that the simple ex vivo labelling procedure used is at least as efficient as more sophisticated alternatives commonly used ' 27 but still in the range of values obtained using tritiated thymidine). By comparing PCNA and BrdU immunoreactivity in a systematic way differences as well as similarities were found. The main difference is the frequency of immunoreactive cells that was almost always higher in PCNA compared with BrdU stained crypts. The two proliferation indices significantly correlated, however, showing that the enhanced detection of PCNA immunoreactivity is a systematic rather than a random phenomenon. Immunohistochemical studies using IgG type anti-PCNA antibodies and BrdU incorporation showed a good correlation in stimulated peripheral blood mononuclear cells.28 In tissues fixed in methanol the PCNA proliferation index did not differ by more than 6% from the tritiated thymidine labelling index." In an animal study, using normal rat colon after in vivo labelling with BrdU and tritiated thymidine no significant differences between the labelling indices with these two DNA precursors and PCNA immunoreactivity was found."0 Another animal study showed a strong correlation between in vivo labelling with tritiated thymidine and PCNA (r=0-982; p= 0-018) and between location of maximal staining for PCNA and tritiated thymidine (r=0.997; p<005).3l The 4-9 (0-2 SEM) 23 33 6-5 (2.5 SD) 24 10 9-3 (0-3 SEM) 10 9.5 (0-3 SEM) 25 19 11-3(03SEM) 26 14 5 8 (1-6 SD) 27 10 5.7(0-7SEM) 21 40 5 9 (0 4 SEM) This study 16 6-9 (2-4 SD) 9-2 (3-6 SD)
Abbreviations as in Table I . Terpstra et al described a decrease in tritiated thymidine proliferation index along the normal looking human colorectum.6 For BrdU, the same has been described by Potten et al.32 If PCNA staining is to be a valid alternative to BrdU or thymidine incorporation studies, it is mandatory that this finding is reproducible with the new technique. We therefore compared BrdU labelling and PCNA staining at various sites along the colorectum and indeed found both parameters of proliferation to decrease from the ascending colon to the rectum. This decrease was more prominent with PCNA staining, which underscores the validity of this technique to measure differences in proliferation.
As Figure 2 shows, small percentages of crypts with BrdU but without PCNA in the upper third of the crypts were seen, but only in the rectosigmoid region. As the PCNA proliferation index is generally higher then that with BrdU, this seems surprising. Figure 5 shows, however, a more prominent decrease in PCNA proliferation index compared with BrdU, suggesting that the number of cells in Gl or G2M phase of the cell cyclus decreases from proximal to distal in the human colon. This 
